DL-TBOA是一种高效且不可转运的兴奋性氨基酸转运蛋白（EAATs）广谱抑制剂。在表达人源EAAT1和EAAT2的COS-1细胞实验中，该化合物能够显著抑制[14C]标记谷氨酸的摄取。此外，DL-TBOA以竞争性方式有效阻断EAAT4和EAAT5的功能。

/

-25~-15℃避光保存，有效期3年。

[1] Pedraz-Cuesta E, Christensen S, Jensen AA, Jensen NF, Bunch L, Romer MU, Brünner N, Stenvang J, Pedersen SF. The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells. BMC Cancer. 2015 May 16;15:411. doi: 10.1186/s12885-015-1405-8. PMID: 25981639; PMCID: PMC4445981.

[2] Sekiya Y, Nakagawa T, Ozawa T, Minami M, Satoh M. Facilitation of morphine withdrawal symptoms and morphine-induced conditioned place preference by a glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate in rats. Eur J Pharmacol. 2004 Feb 6;485(1-3):201-10. doi: 10.1016/j.ejphar.2003.11.062. PMID: 14757142.